Vizgen Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
81
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$85.2M
- Investors
-
8
Vizgen General Information
Description
Developer of biomolecule profiling technology designed to bring new insight into biological systems and disease. The company's technology focuses on unlocking the power of spatially resolved, single-cell gene expression profiling in intact tissue slices using spatial gene profiling measurements, thereby enabling medical researchers to efficiently interrogate biology on a systems scale.
Contact Information
Website
www.vizgen.comCorporate Office
- 61 Moulton Street
- Cambridge, MA 02138
- United States
Corporate Office
- 61 Moulton Street
- Cambridge, MA 02138
- United States
Vizgen Timeline
Vizgen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series C) | 27-Apr-2022 | $85.2M | Completed | Generating Revenue | ||
| 3. Early Stage VC (Series B) | 26-Mar-2021 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 03-Oct-2019 | $14M | $14M | Completed | Generating Revenue | |
| 1. University Spin-Out | 01-Jan-2019 | Completed | Startup |
Vizgen Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 7,349,080 | $0.001000 | $0.15 | $1.91 | $1.91 | 1x | $1.91 | 22.99% |
Vizgen Comparisons
Industry
Financing
Details
Vizgen Competitors (37)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cellecta | Private Debt Financed | Mountain View, CA | ||||
| Egenesis | Venture Capital-Backed | Cambridge, MA | ||||
| Quantapore | Venture Capital-Backed | South San Francisco, CA | ||||
| Avitide | Formerly VC-backed | Lebanon, NH | ||||
| Intellia Therapeutics | Formerly VC-backed | Cambridge, MA |
Vizgen Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Vizgen Patents
Vizgen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230279465-A1 | Methods of anchoring fragmented nucleic acid targets in a polymer matrix for imaging | Pending | 17-Feb-2022 | ||
| AU-2023220122-A1 | Methods of anchoring fragmented nucleic acid targets in a polymer matrix for imaging | Pending | 17-Feb-2022 |
Vizgen Executive Team (10)
| Name | Title | Board Seat |
|---|---|---|
| Terry Lo Ph.D | Chief Executive Officer, President & Board Member | |
| Philip Gardella | Chief Financial Officer | |
| Seth Benson | Chief Financial Officer | |
| Jiang He Ph.D | Co-Founder & Senior Director of Scientific Affairs | |
| George Emanuel | Scientific Co-Founder & Director of Technology & Partnerships |
Vizgen Board Members (7)
| Name | Representing | Role | Since |
|---|---|---|---|
| Andrea Jackson | Northpond Ventures | Board Member | |
| David Walt Ph.D | Self | Co-Founder & Board Member | |
| Keith Crandell | ARCH Venture Partners | Board Member | |
| Marijn Dekkers Ph.D | Novalis LifeSciences | Board Member | |
| Matthew Posard | Self | Board Member |
Vizgen Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Vizgen Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Blue Water Life Science Fund | Hedge Fund | Minority | ||
| David Walt | Angel (individual) | Minority | ||
| Sofina | Growth/Expansion | Minority | ||
| Novalis LifeSciences | Venture Capital | Minority | ||
| Pura Vida Investments | Hedge Fund | Minority |
Vizgen FAQs
-
When was Vizgen founded?
Vizgen was founded in 2019.
-
Who is the founder of Vizgen?
Jiang He Ph.D, George Emanuel, and David Walt Ph.D are the founders of Vizgen.
-
Who is the CEO of Vizgen?
Terry Lo Ph.D is the CEO of Vizgen.
-
Where is Vizgen headquartered?
Vizgen is headquartered in Cambridge, MA.
-
What is the size of Vizgen?
Vizgen has 81 total employees.
-
What industry is Vizgen in?
Vizgen’s primary industry is Biotechnology.
-
Is Vizgen a private or public company?
Vizgen is a Private company.
-
What is the current valuation of Vizgen?
The current valuation of Vizgen is .
-
What is Vizgen’s current revenue?
The current revenue for Vizgen is .
-
How much funding has Vizgen raised over time?
Vizgen has raised $136M.
-
Who are Vizgen’s investors?
Blue Water Life Science Fund, David Walt, Sofina, Novalis LifeSciences, and Pura Vida Investments are 5 of 8 investors who have invested in Vizgen.
-
Who are Vizgen’s competitors?
Cellecta, Egenesis, Quantapore, Avitide, and Intellia Therapeutics are some of the 37 competitors of Vizgen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
